McGill University
MUHC
CIHR

Challenges in Drug Discovery and Clinical Development

The Drug Discovery and Development Forum 2016 will highlight the current challenges in drug research and the clinical development of new drugs.


When: June 6-10 2016

Where: Centre for Translational Biology
McGill University Health Centre
1001 Decarie Boulevard, Bloc E
Montreal, Quebec H4A 3J1

Challenges in Drug Discovery and Clinical Development Forum MUHC McGill University CIHR

Faculty of Medicine - McGill University
Wiley
Merck
Sigma Aldrich
VWR
PeproTech
 
Wisent Biotechnologies
Innovative Medicines Canada
Servier Canada Inc.
 

Forum 2016, a successful event - View photos below:

  • 2nd International Drug Discovery and Development Forum 2016
  • Day 3 – June 8, 2016 – Symposium II
Animal Models and Translational Research
  • DDay 4 – June 9, 2016 – Poster session & Commercial exhibition (Atrium)
  • DDay 4 – June 9, 2016 – Poster session & Commercial exhibition (Atrium)
  • Day 4 – June 9, 2016 – Poster session & Commercial exhibition (Atrium)I

Program Overview

Meet our speakers

Welcome to our invited speakers

Symposium I

Dr. Nada Jabado, McGill University

Dr. Nada Jabado, Professor
McGill University, Canada

Dr. Bernd Kaina

Dr. Bernd Kaina, Director
Institut fur toxikologie, Mainz, Germany

Dr. Asha Das

Dr. Asha Das, Vice President Clinical Development
Tocagen, USA

Dr. Janusz Rak

Dr. Janusz Rak, Professor
McGill University, Canada

Dr. Eric Bouffet

Dr. Eric Bouffet, Professor, Director, Brain Tumour Program, President of the International Society of Pediatric Oncology
University of Toronto, Canada

Dr. Monika Hegi

Dr. Monika Hegi, Professor
University of Lausanne, Switzerland

Dr. Andrew Kung

Dr. Andrew L. Kung, Professor of Pediatrics, Chief of the Division of Pediatric Hematology, Oncology and Stem Cell Transplantation
Columbia University Medical Center, USA

Symposium II

Dr. Rima Al-Awr

Dr. Rima Alawar, Director Drug Discovery Program
Ontario Institute for Cancer Research MaRS

Dr. Paul Haluska

Dr. Paul Haluska, Director Scientific Affairs
Merck Research Institute, USA

Dr. Uri Saragovi

Dr. Uri Saragovi, Professor and Founder of Mimetogen
McGill University, Canada

Dr. Marcel Bally

Dr. Marcel Bally, Professor, Head, Experimental Therapeutics
BC Cancer Agency CDRD

Symposium III

Dr. Alain Wagner

Dr. Alain Wagner, Centre National de Recherche Scientifique, France
The living as reaction media: towards the development of chemo-activated therapeutic agents

Dr. Mildred Duncan-Avecedo

Dr. Mildred Duncan-Avecedo, Professor
University of South Florida, USA

Dr. Karine Auclair

Dr. Karine Auclair, Professor
McGill University, Canada

Dr. Nathanael Gray

Dr. Nathanael Gray, Professor
Harvard Medical School, USA

Symposium IV

Dr. Pierre Chaurand

Dr. Pierre Chaurand, Professor
Université de Montréal, Canada

Dr. David Bonnel

Dr. David Bonnel, Director
ImaBiotech, France

Dr. Sebastien Blais-Ouellette

Dr. Sébastien Blais-Ouellette
Photon ETC, Canada

Dr. Peter Metrakos

Dr. Peter Metrakos, Professor, MUHC Cancer Program Leader
McGill University, Canada

Special Training Sessions

  • Advanced microscopy for drug discovery
  • Mass spectrometry imaging in drug discovery
  • Practical Proteomics
  • Metabolomics
  • Hyphenated LC-NMR-MS
  • Pharmacokinetics in drug discovery
  • MRI and PET of rodent brains

Accommodations at special conference rates are available: $60-$220 CAD/night

IN ORDER TO BENEFIT FROM THE SPECIAL RATES PLEASE WRITE TO US AT:

DDTP Office
1001 Décarie Boulevard Room ES15565
Montreal Quebec
H4A 3J1
Email: trainingindrugdev.med@mcgill.ca
Tel: (514) 934-1934 Ext: 76435

For more information, please contact us at:
Tel: (514)934-1934 ext. 76435
Trainingindrugdev.med@mcgill.ca


Photos from Forum 2015